Spending 30 minutes on a treadmill or an elliptical machine a few times each week is not the key to a healthy lifestyle. What’s more important is getting out of your chair, or off the couch, and moving throughout the day – preferably at least once an hour. That’s the logic behind Anytime Fitness’ new “Every Step Counts” campaign – which features reserved parking spots for its members as far away as possible from the gym, in the far corners of the parking lot.
“We care what you do outside the gym every bit as much as when you’re inside one of our facilities,” said Chuck Runyon, CEO and co-founder of Anytime Fitness. “Three hours of rigorous exercise a week is great. But what you do during the other 165 hours each week will really determine whether you’re healthy or not. If you sit in a chair and stare at a computer screen for eight hours a day, without moving every hour or so, then research* shows you’re much more likely to develop a long list of preventable chronic diseases. Sitting too much is the new smoking.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7942951-anytime-fitness-every-step-counts/
During flu season, when fever, aches, and chills hit, it is easy to forget one’s manners. A recent survey of more than 1,000 Americans found that nearly two-thirds (64%) of those who had influenza in the past three years admit to being “That Guy,” who despite experiencing flu symptoms, continues to go about his/her daily activities.
As part of its “Are You That Guy?” influenza education campaign, the National Foundation for Infectious Diseases (NFID) is partnering with the Emily Post Institute to remind Americans to do the responsible thing during flu season and practice behavior that will help limit the spread of influenza, a highly contagious virus. The campaign also reminds Americans to see a doctor quickly if flu strikes. The campaign offers flu etiquette tips for managing common situations where the flu virus might be shared from one person to another, such as shaking hands during a business meeting, over a family dinner, or when faced with a fellow airplane traveler who is showing signs of flu.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53536-nfid-emily-post-institute-educate-about-spreading-manners-not-influenza
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Many people suffer from eczema and various skin disorders that they don’t understand. The names for these skin disorders are numerous – eczema, psoriasis, dermatitis, hives, allergies, scales, and so on. Most standard medical treatments fail to cure or give lasting relief to some of these disorders. This makes it so frustrating for those with these diseases since even dermatologists and doctors find it difficult to find a cure for them.
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Summit Homes, a Berkshire Hathaway subsidiary through Clayton Properties Group, presented St. Jude Children’s Research Hospital representatives a check for $718,000 following the sale of the builder’s 2017 St. Jude Dream Home Showplace.
Summit Homes, the largest new home builder in Kansas City, built the 2017 St. Jude Dream Home Showplace as an extension of the St. Jude Dream Home® Giveaway Program, to support children battling cancer and other catastrophic diseases. The builder pledged 100% of proceeds from the sale of the home to as a donation for the research hospital.
To view the multimedia release go to:
https://www.multivu.com/players/English/8011654-clayton-summit-homes-st-jude-dream-home-2017/
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
